FLT1 and neoplasm: It binds to VEGF receptor 1 (VEGFR-1) and inhibition of PlGF or VEGFR-1 has been reported to reduce tumour growth and angiogenesis (Carmeliet et al, 2001; Hiratsuka et al, 2002; Fischer et al, 2007).